These results are supported by several reports suggesting that IL-6 is a downstream target of the CXCR4 signaling pathways58, 59, and tumor malignancy occurs through the IL-6-induced activation of the JAK/STAT3/Snail pathway60. Here, IL6 is linked to neoplasm.